Efficacy of Multimodal Analgesia Following Hip Arthroscopy
common.study.values.description
“Efficacy of Multimodal Analgesia Following Hip Arthroscopy”
The purpose of the full study is to determine whether multimodal analgesia for hip arthroscopy will reduce post-operative pain scores, narcotic consumption and hospital length-of-stay. To do this, the investigators will compare the standard of care (SOC), with routine pain management with a post-operative opioid prescription, to three different groups with multi-modal analgesia (SOC+peri-operative celecoxib, SOC+peri-operative gabapentin, and SOC+post-operative zopiclone). The investigators hypothesize that administration of multi-modal analgesia in all three treatment groups will result in improved post-operative pain control, reduced post-operative narcotic consumption and an overall reduction in post-operative length-of-stay compared to the group receiving treatment as per the standard of care. However, prior to undertaking a large multi-centre study, the investigators need to determine whether the study is feasible from data obtained with this pilot study.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Drug - Naprosyn
Standard of Care
Drug - Percocet
Standard of Care
Drug - Zopiclone
Group 2 - Zopiclone 7.5 mg orally, nightly for 7 days
Drug - Gabapentin
Group 3 - Gabapentin 600 mg orally, 1 hour pre-operatively and 600 mg orally, 8 hours post-operatively
Drug - Celebrex
Group 4 - Celebrex 400 mg PO, 1 hour pre-operatively
participant.views.study.view.additional
participant.views.study.view.scientific-title
Efficacy of Multimodal Analgesia Following Hip Arthroscopy
common.study.values.clinical-trial-id
NCT03351439
participant.views.study.view.id
PdRx0a